FDA
approval
· 2021-04-30
FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Zydus Lifesciences Limited)
Summary
FDA approved a supplemental application from Zydus Lifesciences Limited for a generic fixed-dose combination of candesartan cilexetil and hydrochlorothiazide fo…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE)